MedTrace Logo

Multicenter Registry of Atrial Fibrillation Ablation With Radiofrequency Balloon Catheter

NCT06333327 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2024-03-27

No results posted yet for this study

Summary

All consecutive patients with paroxysmal or persistent atrial fibrillation undergoing pulmonary vein isolation with the radiofrequency balloon catheter (RFB) "Heliostar" (Biosense Webster) will be included in a multicenter observational registry. The aim of the study is to assess the safety and arrhythmic outcome of atrial fibrillation ablation with the RFB in a real-world setting.

Conditions

Interventions

DEVICE

Pulmonary vein isolation with the multielectrode radiofrequency balloon catheter

Pulmonary vein isolation with the multielectrode radiofrequency balloon catheter

Sponsors & Collaborators

  • Universitair Ziekenhuis Brussel

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2030-01-01
Completion
2030-12-01

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06333327 on ClinicalTrials.gov